ArticleTranslational lung cancer research2021

Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer.

Chunxia Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.